{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-011724","form_type":"8-K","ticker":"TWST","cik":"0001581280","company_name":"Twist Bioscience Corp","filed_at":"2022-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.189283+00:00","generated_at":"2026-06-27T11:04:25.141218+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Twist Bioscience Q1 FY2022: revenue $42M (+49% YoY), orders up 48%, raises FY guidance","bullets":["Revenue of $42.0M (up 49% from $28.2M YoY); orders of $49.6M (up 48% from $33.6M).","Net loss $45.6M ($0.91 per share) vs $32.9M ($0.72 per share) in prior year.","Cash, cash equivalents and investments $408.7M as of Dec 31, 2021; shipped to ~1,800 customers.","Raised fiscal 2022 revenue guidance; specific numbers not provided in the press release excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-011724","json":"https://secwatch.observer/filing/0001104659-22-011724.json","markdown":"https://secwatch.observer/filing/0001104659-22-011724.md","text":"https://secwatch.observer/filing/0001104659-22-011724.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1581280/000110465922011724/0001104659-22-011724-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1581280/000110465922011724/tm224740d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T11:04:25.141218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}